All Stories

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing

Johnson & Johnson's proposed $14.6 billion purchase of Intra-Cellular Therapies took just one month from the time the buyer revealed its intention to the signing of the deal. The process involved a key intervention from J&J’s CEO Joaquin Duato, a securities filing shows.

Feb 9, 2025 - 21:43
 0
J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind month: filing
Johnson & Johnson's proposed $14.6 billion purchase of Intra-Cellular Therapies took just one month from the time the buyer revealed its intention to the signing of the deal. The process involved a key intervention from J&J’s CEO Joaquin Duato, a securities filing shows.
Read More

Tags:

Previous Article

China's economy gets New Year boost from holiday travel and shopping

Next Article

Chine : Consommation et tourisme en hausse à l'occasion du nouvel an

Related Posts

Moderna trims digital team, lays off employees as chief information officer departs

Moderna trims digital team, lays off employees as chief...

Feb 13, 2025  0

Once valued at $10B, bluebird bio sold to private equity firms for $29M

Once valued at $10B, bluebird bio sold to private equit...

Feb 21, 2025  0

Is it time for HLS to embrace industry-specific cloud?

Is it time for HLS to embrace industry-specific cloud?

Feb 10, 2025  0